Invention Grant
- Patent Title: KRAS G12C inhibitors and methods of using the same
-
Application No.: US16402589Application Date: 2019-05-03
-
Publication No.: US11045484B2Publication Date: 2021-06-29
- Inventor: Ryan Paul Wurz , Victor J. Cee , Albert Amegadzie , Ning Chen , Brian Alan Lanman , Michael D. Bartberger
- Applicant: Amgen Inc.
- Applicant Address: US CA Thousand Oaks
- Assignee: Amgen Inc.
- Current Assignee: Amgen Inc.
- Current Assignee Address: US CA Thousand Oaks
- Agent Markus Bergauer
- Main IPC: A61K31/675
- IPC: A61K31/675 ; A61P35/00 ; A61K31/167 ; A61K31/553 ; C07K16/30 ; A61K45/06
Abstract:
Provided herein are KRAS G12C inhibitors, composition of the same, and methods of using the same. These inhibitors are useful for treating a number of disorders, including pancreatic, colorectal, and lung cancers.
Public/Granted literature
- US20190336514A1 KRAS G12C INHIBITORS AND METHODS OF USING THE SAME Public/Granted day:2019-11-07
Information query
